Peer-reviewed veterinary case report
Lomustine and steroids as treatment for cats with brain lymphoma
By Claudia Pauciulo et al.·Published in Journal of the American Veterinary Medical Association·2025·View original on Semantic Scholar →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: The combination of lomustine and corticosteroids is a valid chemotherapeutic option in cats with presumptive central nervous system lymphoma.
- Species:
- cat
Plain-English summary
A 10-year-old cat with central nervous system lymphoma was treated with a combination of lomustine and corticosteroids after showing symptoms like difficulty walking and ataxia (loss of coordination). The cat had been experiencing these issues for about a week, and imaging tests revealed lymphoma in the spinal area. After treatment, 70% of the cats in the study were still alive after three months, with some showing continued improvement at six and twelve months. The treatment was well-tolerated with no significant side effects reported.
People also search for: cat CNS lymphoma treatment · lomustine for cats · cat ataxia causes · cat seizures treatment · cat cancer survival rates
Abstract
Objective To describe the clinical outcomes of 10 cats diagnosed with CNS lymphoma treated with lomustine and corticosteroids. Animals Clinical records of privately owned cats diagnosed with CNS lymphoma and presented to a neurological veterinary center were reviewed. Inclusion criteria were MRI, CSF analysis, treatment with corticosteroids and lomustine, and availability of detailed follow-up data. Cats with incomplete data, alternative diagnoses, or concomitant intracranial conditions as well as those improving after corticosteroid treatment before the diagnosis were excluded. Ten cats met the inclusion criteria. Clinical Presentation The median duration of clinical signs was 7 days. All patients presented with locomotor deficits; 90% exhibited ataxia. Paresis was observed in 60%, and spinal pain on palpation was also described in 60% of the cats. Cranial nerve abnormalities were identified in 30% and epileptic seizures were reported in 20% of the cats. Results MRI revealed intracranial lymphoma in 40% and spinal lymphoma in 60% of the cases and contrast-enhancing lesions with meningeal involvement in most of the cases. One cat had elevated CSF cell counts; the others showed normal cell counts but atypical lymphocytes. Seven cats (70%) were still alive at the 3-month follow-up, with 3 (30%) maintaining improvement at 6 and 12 months. The treatment did not result in any significant adverse effect. Clinical Relevance The combination of lomustine and corticosteroids is a valid chemotherapeutic option in cats with CNS lymphoma. Larger prospective studies are warranted to compare efficacy of this treatment with that of other chemotherapeutic protocols.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on Semantic Scholar: https://www.semanticscholar.org/paper/41072475